Video

Q&A With Richard Lewis, MD, FAAN, of Cedars Sinai: Taking the Next Steps in CIDP Treatment

Author(s):

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

There are mechanisms in place to monitor treatment success but Richard Lewis, MD, from Cedars Sinai said it is important to have people familiar with the condition to monitor patient health in order to assure them the best possible outcome. Lewis spoke during the American Academy of Neurology's annual meeting in Washington DC. 

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.